Archives
-
TP53, ATM, and MDM2 in Calicheamicin Sensitivity
2026-09-04
This acute leukemia study uses genome-wide CRISPR/Cas9 screening and matched genetic models to define how DNA damage sensing shapes response to calicheamicin, the payload shared by gemtuzumab ozogamicin and inotuzumab ozogamicin. Its key translational result is that TP53 loss confers strong resistance, whereas pharmacologic ATM or MDM2 modulation can enhance calicheamicin activity; PARP inhibition did not produce the same effect in the tested models.
-
Machine Learning Designs LNPs to Reprogram Microglia
2026-09-03
A 2025 Drug Delivery study combined a 216-formulation lipid nanoparticle library with supervised machine learning to identify carriers that deliver mRNA and modulate hyperactivated microglia. The optimized HA-LNP2 formulation improved IL10 expression and reduced TNF-α-associated inflammatory responses in murine and human iPSC-derived microglia, illustrating how carrier immunological properties can be treated as design variables.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-09-03
The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through a B4GALT1–PD-L1 stability axis. RBMS1 depletion reduced PD-L1 abundance, increased cytotoxic T-cell activity, and improved responses to CTLA4 blockade or CAR-T treatment in cellular and animal models.
-
Chlorpromazine HCl Beyond Dopamine: A Translational Lens
2026-09-02
Chlorpromazine HCl is more than a conventional dopamine receptor antagonist: it is a pharmacological probe for connecting receptor signaling, synaptic physiology, endocytosis, and host-cell defense. This thought-leadership guide outlines how translational researchers can use its established neuropharmacology while responsibly evaluating emerging phenothiazine biology in infection and cell-based research.
-
Adipose-Neural Signaling in Cardiac Arrhythmias
2026-09-02
The reference preprint identifies a leptin–NPY pathway linking epicardial adipose tissue to sympathetic neurons and arrhythmic cardiomyocyte behavior. Its co-culture and patient-association data provide a mechanistic framework for studying neuro-adipose contributions to arrhythmia while highlighting the need for validation in more complex models.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-09-01
Use TPA as a fast, controllable protein kinase C and ERK/MAPK pathway perturbation tool, from phospho-ERK time courses to biochemical kinase assays and skin cancer models. This workflow also shows how TPA can strengthen mechanistic studies of the GRB2–ERK1/2–mTOR axis identified in cisplatin-resistant ovarian cancer research.
-
7-dehydro Cholesterol as a Metabolic State Variable
2026-09-01
7-dehydro Cholesterol is more than a cholesterol precursor: it is a photoreactive, oxidation-sensitive metabolic state variable. This article shows how to interpret DHCR7, UVB, sterol, and immune data without confusing substrate exposure with genetic pathway disruption.
-
Indomethacin: Practical Research Protocol and QC Guide
2026-08-31
This guide explains how to use Indomethacin as a controlled perturbation tool in inflammation research, lipid metabolism studies, and membrane signaling experiments. It is suitable for solvent-controlled biochemical or cell-based workflows, but should not be treated as a pathway-specific probe or used for mechanistic attribution without orthogonal controls.
-
Rapamycin: A Metabolic Stress Test for mTOR
2026-08-31
Rapamycin (Sirolimus) can do more than inhibit mTOR: it can help researchers test how nutrient stress, lipotoxicity, and cell survival are causally connected. This guide translates recent PARP-1–mTORC1–p300 findings into practical assay-design decisions.
-
Neuritin, ER Stress, and NF-κB After SAH
2026-08-30
The reference study defines a mechanistic link between endoplasmic reticulum stress, NF-κB-associated neuroinflammation, and neuronal apoptosis during early brain injury after subarachnoid hemorrhage. Its central finding is that neuritin overexpression suppresses three ER stress-related inflammatory branches, supporting neuritin as a preclinical neuroprotective target and identifying NF-κB convergence as a useful experimental readout.
-
Rapid Purification of Recombinant Annexin V
2026-08-29
Burger and colleagues introduced a short purification strategy for recombinant annexin V that combines mild osmotic opening of Escherichia coli with reversible calcium-dependent capture on liposomes and final ion-exchange chromatography. The resulting analytical purity was designed to support demanding biophysical experiments, including crystallography, electron microscopy, spectroscopy, and single-channel measurements.
-
10 mM dNTP Mixture for Reliable DNA Workflows
2026-08-28
Build reproducible PCR, qPCR, sequencing, and DNA-tracking workflows with a ready-to-use equimolar nucleotide source. This guide connects practical dNTP handling with a 2025 study showing how cholesterol can impede lipid nanoparticle trafficking, while clearly separating established reagent use from emerging delivery research.
-
Leucovorin Calcium in Gastric Cancer Assembloids
2026-08-28
Leucovorin Calcium, also known as calcium folinate, offers translational researchers a mechanistically grounded way to study methotrexate rescue within patient-derived gastric cancer assembloids. By combining folate pathway perturbation with matched tumor and stromal models, researchers can move beyond simple viability readouts toward more informative analyses of microenvironment-dependent response and antifolate resistance.
-
Protease Inhibitor Cocktail for Protein Workflows
2026-08-27
Protect labile targets such as METTL3, HSP90, and MYC-associated complexes from ex vivo proteolysis during lysis, Western blotting, and co-immunoprecipitation. This two-component format combines broad-spectrum protease inhibition with separate EDTA, allowing researchers to include or remove metalloprotease protection according to downstream assay chemistry.
-
Lipo3K Transfection Reagent for APOL1 Studies
2026-08-27
Build cleaner APOL1 isoform, variant, and APOL3 interaction assays with a low-toxicity lipid transfection reagent. This workflow combines plasmid enhancement, siRNA optimization, and viability controls for difficult cell models.